The percutaneous electrical nerve stimulators market is projected to grow from USD 311.3 million in 2025 to USD 547 million by 2035, with a CAGR of 5.8% during the forecast period. Chronic musculoskeletal pain dominates the industry with 32% share, while percutaneous needle-based stimulators are projected to capture 28% of the industry share in 2025.